3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Ganglioneuroblastoma
2
Recurrence
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Blast Crisis
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
venetoclax
5
Rituximab
5
Cyclophosphamide
5
zanubrutinib
3
Whole-Body Irradiation
3
Prednisone
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Cyclosporine
3
pirtobrutinib
2
fludarabine phosphate
2
fludarabine
2
Vincristine
2
Specimen Handling
2
Mycophenolic Acid
2
Doxorubicin
2
Biopsy
2
treosulfan
1
pomalidomide
1
polatuzumab vedotin
1
obinutuzumab
1
ibrutinib
1
Tacrolimus
1
Stem Cell Transplantation
1
Sirolimus
1
R-CHOP protocol
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Methotrexate
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Thiotepa
×
30 days
×
Clear all
No trials found.